You are here

Article Text

Article menu
Download PDFPDF
JournalScan
Cardiovascular highlights from non-cardiology journals
  1. James M McCabe
  1. University of Washington, Seattle, Washington, USA
  1. Correspondence to Dr James M McCabe, University of Washington, 1959 NE Pacific St, Box 356422, Seattle, WA 98195, USA; jmmccabe{at}cardiology.washington.edu

https://doi.org/10.1136/heartjnl-2017-311687

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Bleeding versus thromboembolic protection in atrial fibrillation and coronary stent procedures

    Five to 8% of people undergoing percutaneous coronary intervention (PCI) also have atrial fibrillation (AF). The optimal antiplatelet / anticoagulant regimen in these individuals remains unclear as stroke and stent thrombosis prevention need to be balanced against the risks of major bleeding. The PIONEER AF-PCI trial randomised 2124 patients with AF who had undergone PCI to 1 of 3 …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.